BJU International

BJUI provides the highest standard of research and clinical info, promoting awareness of advances and supporting best practice | Editor-in-Chief: Freddie Hamdy

[BJU International @BJUIjournal]

Looking for the best home for your urology research?

Find out why BJUI could be the right journal for you.

https://t.co/5YjH6VJulu

[Alastair Lamb @LambAlastair]

Nice summary of Artificial Intelligence >> Machine Learning >> Deep Learning from @michael_gorin
to kick off @BJUIjournal session at #AUA25

Will image segmentation CNNs provide answer to IDing "potentially lethal" prostate cancer (on MRI or histology)? I think so!

#SPACE_Study

[Alastair Lamb @LambAlastair]

@lawrentschuk lays out a nice template for how to safely employ existing (& future) #AI modalities in urological practice

@BJUIjournal session at #AUA25

S-afe for patients & staff
A-fforable & accurate
F-used with existing technologies
E-asy to use

Great demo of AI-scribes

[BJU International @BJUIjournal]

Please note, you can now find us at the other place

[BJU International @BJUIjournal]

Festive Greetings from BJUI

[BJU International @BJUIjournal]

The balls of the ideal man?
Read December's BJUI online now! Click here for the table of contents
https://t.co/HaPlf9p8zy

[Imperial Prostate @IP_London]

The protocol paper for the IP8-FLUORESCE trial is now published #openaccess in @BJUIjournal! Excellent work led by @NikhilMayor and @SageOfLondon1

Keep tuned for the results!

Read for free: https://t.co/Ywrg9xZj1p

[BJUI Knowledge @bjuiknowledge]

In addition to our multimedia content, this #Movember browse #OpenAccess articles published in @BJUIjournal and @BJUIcompass. Including ‘#ProstateCancer and solid organ transplantation: patient management and outcomes’ – authored by @uroegg et al.

https://t.co/bzFBuppOVn

[IU Simon Comprehensive Cancer Center @IUCancerCenter]

The cancer center’s Timothy A. Masterson, MD, Clint K. Cary (@ClintCaryMD), MD, and colleagues uncover insights in a new article published in @BJUIjournal. Learn more: https://t.co/BQvuXczPB9. #ResearchCuresCancer #NCIcomprehensive

[Shekhar Biyani @shekharbiyani]

1st Emergency Urology Boot Camp in #Hawassa 🇪🇹such a resounding success. Thanks to ⁦@BJUIjournal⁩ Excellent teamwork ⁦@MrWillFinch⁩ ⁦@MatthewTrail⁩ Steve Payne colleagues from Hawassa and Addis. ⁦@BAUSurology⁩ ⁦@cosecsa⁩ ⁦⁦@UrologyBootCamp⁩

[Matthew Trail @MatthewTrail]

Incredibly rewarding week in Hawassa 🇪🇹 with the #Urolink team - 11 PCNLs in 4 days with excellent progress by the local team and an inaugural national bootcamp for trainees - exciting times ahead for Ethiopian Urology! @MrWillFinch @shekharbiyani @BAUSendourology @BJUIjournal

[Axel S. Merseburger @amerseburger]

Just in 👉 @BJUIjournal in this post hoc analysis of TITAN we show, that patients with the deepest PSA decline derived the greatest benefit in #mHSPC #ProstateCancer
Link: https://t.co/9e8xBOxOCP
@urotoday @OncoAlert @Uroweb

[BJU International @BJUIjournal]

The non-coding RNA based classifier identifies urothelial carcinomas harboring less aggressive tumor biology associated with favorable outcomes after radical cystectomy
@JoepJdeJong @UTSWUrology @siadaneshmand @UrogerliMD @Davicioni @Decipher_VCYT

https://t.co/n5vnVIdAgC

[Enrique Grande @drenriquegrande]

⚡️ Comparative effectiveness of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer

#BladderCancer @ThoSeisen @BJUIjournal

https://t.co/GaeUdLefF4

[BJU International @BJUIjournal]

An international multi-centre RCT on ERBT vs conventional TURBT: First results of the EBRUC II trial

https://t.co/SoWbV1Dbxw

[BJU International @BJUIjournal]

Ventral buccal mucosa graft #urethroplasty for bulbar urethral stricture disease confers high patient satisfaction & success rates w/ low decisional regret @ extended follow-up using emerging and validated patient-reported outcome measures @SocietyGURS
https://t.co/LnJWjRJeBF

[BJU International @BJUIjournal]

Primary RPLND, performed by experienced surgeons, has good peri-operative outcomes. Recurrence is more common than with standard treatment, but long-term survival and functional data are limited, although promising. @lawrentschuk
https://t.co/Q3s1rhOF8C

[BJU International @BJUIjournal]

Comparative effectiveness of iRARC vs. ORC for #BladderCancer: findings from a real life study show better perioperative outcomes with similar cancer control and ureteroileal stricture outcomes after iRARC
@ThoSeisen
https://t.co/WnBILv2xVf

[BJU International @BJUIjournal]

Exploring the potential of bladder irrigation with tap water as an effective
and patient-friendly alternative for UTI treatment in catheter users.
#UTI #AntibioticResistance #SustainableHealthcare
https://t.co/2UYHNuP42X

[BJU International @BJUIjournal]

Pre- and postradical cystectomy tumor-informed ctDNA dynamics is a powerful predictor of oncological outcomes: those who convert from detectable to undetectable ctDNA fare worse than those staying undetectable
@ReubenBenDavid1 @MehrazinMD @DrJohnSfakianos
https://t.co/DMg9UxALNT